Medical Oncology in Mankato, MN
5 verified medical oncology doctors in Mankato.
Medical oncologists diagnose and treat cancer, coordinating chemotherapy and other systemic cancer therapies.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Kevin Cockerill, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Glenn Harman, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mohammad Ranginwala, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Amrit Singh, MD
Medical Oncology
CMS Open Payments· $43.91 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$43.91
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is on the lower end — around the 44th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Amrit Singh do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Karan Seegobin, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.